Custom Search


Portfolio of Biotech Stocks: Cancer

Here is a sample of 18 biotech stocks that provide cancer detection and treatments.

Biotech Stocks: Cancer
Stock
Price Quote & Dividend
1-Yr Price Chart
Amgen
Ariad Pharmaceuticals
Array BioPharma
Celgene
Celldex Therapeutics
Endocyte
Exelixis
ImmunoCellular Therapeutics
ImmunoGen
Incyte Corporation
Juno Therapeutics
Medivation
OncoMed Pharmaceuticals
Puma Biotechnology
SciClone Pharmaceuticals
Seattle Genetics
Spectrum Pharmaceuticals
Tesaro
Price and dividend data from Quandl.


To inspect the performance of the Biotech Stocks: Cancer portfolio, see the returns table and chart below. Portfolio values are computed using monthly closes for from Quandl.

The 13 included in the portfolio computations are: AMGN, ARIA, ARRY, CELG, CLDX, EXEL, IMUC, IMGN, INCY, MDVN, SCLN, SGEN and SPPI. The current value of the portfolio assumes that $769.23 was invested (total of $10,000) in each at its closing weekly price for the current date in 2008. The 5 excluded from the portfolio computations because of insufficient price data are: ECYT, JUNO, OMED, PBYI and TSRO.






Related Articles

Portfolio of Big Pharmaceuticals Stocks: Cancer
Portfolio of Big Pharma and Biotech Cancer Immunotherapy Stocks
Portfolio of Biotech Stocks: Arthritis
Portfolio of Biotech Stocks: Diabetes
Portfolio of Biotech Stocks: Hepatitis C
Portfolio of Dividend-Paying Pharmaceutical Stocks
Portfolio of Gene Editing (CRISPR) Stocks